Following a total joint replacement, anticoagulation (blood thinning) drugs can prevent Deep Vein Thrombosis (DVT), a blood clot deep within the extremities, or a pulmonary embolism (PE), a complication that causes a blood clot to move to the lungs. However, prolonged use of these therapies may increase the risk of hemorrhage and infection… Blood / [...]
Uncategorized
Is Economy Class Air Travel Linked To Blood Clot Risk? Apparently Not
February 8, 2012
“Economy Class Syndrome” is a myth, your risk of developing a blood clot during a long-distance economy trip by plane is not higher than in first class, researchers report in an article published in Chest… Blood / Hematology News From Medical News Today
For Atrial Fibrillation Patients At Risk For Stroke, Easy-To-Use Blood Thinners Likely To Replace Coumadin
February 8, 2012
Within a few years, a new generation of easy-to-use blood-thinning drugs will likely replace Coumadin for patients with irregular heartbeats who are at risk for stroke, according to a journal article by Loyola University Medical Center physicians. Unlike Coumadin, the new drugs do not require patients to come in to the clinic on a regular [...]
Racial Disparities Likely Reduced By Sickle Cell Anemia Stroke Prevention Efforts
February 7, 2012
The disparity in stroke-related deaths among black and white children dramatically narrowed after prevention strategies changed to include ultrasound screening and chronic blood transfusions for children with sickle cell anemia, according to research presented at the American Stroke Association’s International Stroke Conference 2012… Blood / Hematology News From Medical News Today
Mandatory Sickle Cell Trait Screening For Athletic Participation Opposed By American Society Of Hematology Policy
January 30, 2012
The American Society of Hematology (ASH), the world’s largest professional society concerned with the causes and treatment of blood disorders, has issued a policy statement* opposing mandatory screening of athletes for sickle cell trait as a prerequisite to athletic participation and urging athletics programs to adopt universal preventive interventions in their training program… Blood / [...]
New Catalytic Process Could Convert By-Products Of Diesel Production Into Anticoagulant Drugs And More
January 28, 2012
A new catalytic process discovered at Cardiff University could unleash a range of useful new by-products from diesel fuel production. More sustainable production of sulphur-free diesel from natural gas and biomass is increasing. However the by-products, hydrocarbons like decane and other low value alkanes have little practical use… Blood / Hematology News From Medical News [...]
A ‘Disruptive Science’ Ready For Commercial Development – Gene Therapy
January 26, 2012
The time for commercial development of gene therapy has come. Patients with diseases treatable and curable with gene therapy deserve access to the technology, which has demonstrated both its effectiveness and feasibility, says James Wilson, MD, PhD, Editor-in-Chief of Human Gene Therapy in a provocative commentary and accompanying videocast… Blood / Hematology News From Medical [...]
Blood-Forming Stem Cells’ Growth Identified
January 26, 2012
Scientists with the new Children’s Research Institute at UT Southwestern Medical Center have identified the environment in which blood-forming stem cells survive and thrive within the body, an important step toward increasing the safety and effectiveness of bone-marrow transplantation. Institute investigators led by Dr… Blood / Hematology News From Medical News Today
Chemists Unlock Potential Target For Drug Development
January 24, 2012
A receptor found on blood platelets whose importance as a potential pharmaceutical target has long been questioned may in fact be fruitful in drug testing, according to new research from Michigan State University chemists. A team led by Dana Spence of MSU’s Department of Chemistry has revealed a way to isolate and test the receptor [...]
